GENPF OTC
Genix Pharmaceuticals Corporation
1W: +0.0%
1M: +0.0%
3M: -8.6%
YTD: -54.0%
1Y: +0.0%
3Y: -90.6%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$124K
+33.8% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$124K
+33.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$32K
+21317.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$1M | -$4M | -$73K | -$335K |
| Depreciation & Amort. | $537K | $564K | $547K | $1K | $1K |
| Stock-Based Comp. | $809K | $259K | $59K | $27K | $0 |
| Change in Working Capital | -$124K | -$6K | $56K | $30K | $32K |
| Other Non-Cash Items | $2K | $9K | $4M | -$172K | $177K |
| Operating Cash Flow | -$428K | -$220K | -$221K | -$187K | -$124K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$3K | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$3K | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$3K | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$14K | $148K | $282K | $187K | $57K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$115K | -$55K | -$59K | $0 | $0 |
| Financing Cash Flow | -$129K | $93K | $223K | $187K | $156K |
| Net Change in Cash | -$558K | -$130K | $2K | -$151 | $32K |
| Cash End of Period | $139K | $9K | $12K | $11K | $44K |
| Free Cash Flow | -$428K | -$223K | -$221K | -$187K | -$124K |